Browsing Tag
Zoetis
4 posts
Elanco (NYSE: ELAN) wins USDA nod for Befrena monoclonal antibody in canine dermatology
Elanco wins USDA approval for Befrena to treat canine dermatitis. Find out how this boosts its antibody strategy and reshapes competition in pet health.
January 1, 2026
Zoetis (NYSE: ZTS) gains EMA panel endorsement for Lenivia — Could this reshape the €10bn companion-animal market?
Zoetis (NYSE: ZTS) earns EMA panel endorsement for Lenivia, a long-acting antibody injection for canine osteoarthritis pain. Find out what this means for investors and the veterinary industry.
October 11, 2025
Portela nears EU approval: Will Zoetis’ quarterly cat pain injection reshape veterinary care?
Zoetis earns CVMP approval recommendation for Portela , a long-acting anti-NGF antibody for feline OA pain. Learn how it could transform veterinary care.
September 13, 2025
Syngene signs Librela-focused biologics manufacturing agreement with Zoetis
Syngene International Limited has signed a 10-year biologics manufacturing agreement with American animal health company Zoetis for manufacturing…
July 17, 2022